Correlation Between Royal Canadian and Cipher Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Royal Canadian and Cipher Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Royal Canadian and Cipher Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Royal Canadian Mint and Cipher Pharmaceuticals, you can compare the effects of market volatilities on Royal Canadian and Cipher Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Royal Canadian with a short position of Cipher Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Royal Canadian and Cipher Pharmaceuticals.

Diversification Opportunities for Royal Canadian and Cipher Pharmaceuticals

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Royal and Cipher is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Royal Canadian Mint and Cipher Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cipher Pharmaceuticals and Royal Canadian is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Royal Canadian Mint are associated (or correlated) with Cipher Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cipher Pharmaceuticals has no effect on the direction of Royal Canadian i.e., Royal Canadian and Cipher Pharmaceuticals go up and down completely randomly.

Pair Corralation between Royal Canadian and Cipher Pharmaceuticals

Assuming the 90 days trading horizon Royal Canadian Mint is expected to generate 0.38 times more return on investment than Cipher Pharmaceuticals. However, Royal Canadian Mint is 2.65 times less risky than Cipher Pharmaceuticals. It trades about -0.13 of its potential returns per unit of risk. Cipher Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest  3,987  in Royal Canadian Mint on August 29, 2024 and sell it today you would lose (184.00) from holding Royal Canadian Mint or give up 4.61% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Royal Canadian Mint  vs.  Cipher Pharmaceuticals

 Performance 
       Timeline  
Royal Canadian Mint 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Royal Canadian Mint are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Royal Canadian may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Cipher Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cipher Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Royal Canadian and Cipher Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Royal Canadian and Cipher Pharmaceuticals

The main advantage of trading using opposite Royal Canadian and Cipher Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Royal Canadian position performs unexpectedly, Cipher Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cipher Pharmaceuticals will offset losses from the drop in Cipher Pharmaceuticals' long position.
The idea behind Royal Canadian Mint and Cipher Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stocks Directory
Find actively traded stocks across global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Valuation
Check real value of public entities based on technical and fundamental data